Searched for
OZEMPIC AND WEGOVY
GLP-1 drugs for weight loss Ozempic, Wegovy linked to vision loss: What is NAION, who is at risk and what symptoms should users watch for?Side effects of weight loss drugs: The makers of GLP-1 weight loss drugs such as Ozempic, Wegovy and Mounjaro must add a warning label abou...- US FDA adds rare vision-loss warning to popular GLP-1 drugsThe US FDA will add a warning about a rare eye condition that can cause permanent vision loss to the labels of all GLP-1 drugs, including O...
- Ozempic Zepbound eye risk warnings: Diabetes, weight-loss drugs Novo Nordisk's Ozempic, Wegovy, Eli Lilly's Mounjaro, Zepbound pose potential threat to eye, sudden vision loss, warns US FDAEli Lilly's Mounjaro and Zepbound and Novo Nordisk's Ozempic and Wegovy were under scanner of United States Food and Drug Administration (U...
- GLP-1 boom in China, India, Brazil could create $22 billion market by 2035, J.P. Morgan saysThe China-India-Brazil market for GLP-1 weight-loss drugs could expand to $22 billion by 2035 from $6.6 billion currently, J.P. Morgan esti...
- Dr Reddy's rolls out new generic Ozempic brands amid Obeda supply disruptionDr Reddy’s Laboratories has expanded its generic semaglutide portfolio with Obeda Pro and Obeda Plus after supplies of its original Obeda i...
- Heineken document reveals worries over weight-loss drugs and beer salesHeineken has warned UK pubs about the increasing impact of weight-loss drugs on beer sales. These medications may reduce consumers' desire ...
- Beauty firms chase 'Ozempic face' market as weight-loss drugs boomGalderma, Natura, and L'Oreal are developing treatments for consumers experiencing facial sagging due to rapid weight loss. These companies...
- As weight-loss drug users turn to dietary supplements, doctors, regulators raise flagsThe growing use of GLP-1 weight-loss drugs such as Ozempic and Wegovy is driving demand for dietary supplements in the US, as users seek to...
- GLP-1 and fertility: Could weight-loss medicines help women conceive? Here's what new reports revealinsulin resistance can disrupt reproductive hormones. For women with polycystic ovary syndrome (PCOS), ovulation may become irregular. Gett...
- GLP-1 users are suing over vision loss: What does the evidence really show?Dozens of patients have taken legal action against drug manufacturers, filing personal injury lawsuits that allege they were not adequately...
- Ozempic maker Novo Nordisk sets sights on hair-loss marketThe condition is part of a list of areas, including addiction and menopause, where Novo sees potential overlap with either its core scienti...
- Wegovy maker Novo Nordisk faces investor pressure to find growth beyond weight-loss drugsFacing increased scrutiny, Novo Nordisk must clarify its future strategy outside of its leading weight-loss drug. Investors are advocating ...
- Novo Nordisk price cuts set to shake up India’s GLP-1 market, challenge genericsNovo Nordisk is slashing prices for its diabetes and weight loss drugs Ozempic and Wegovy in India. This move aims to make these treatments...
- Novo Nordisk gears up for December Ozempic launch in India, sources sayDanish drugmaker Novo Nordisk is set to launch its popular diabetes drug Ozempic in India this month. This move aims to capture a significa...
- Novo Nordisk launches limited offer: New patients can start Ozempic or Wegovy for $199 a monthNovo Nordisk is offering a new discount on its GLP-1 drugs Ozempic and Wegovy for a short time. The prices are lower for both new and exist...
- Costco to sell Ozempic and Wegovy at huge discounts — even if you don’t have insuranceCostco offers huge Ozempic and Wegovy discounts. Members can save on these diabetes and weight loss medications. The program makes life-cha...
- Novo Nordisk's stock rises as Ozempic beat analysts' expectations in salesIn its outlook for 2025, Novo Nordisk has predicted 'continued periodic supply constraints and related drug shortage notifications'.
- Novo Nordisk not yet ready to bring in popular obesity, diabetes injectablesNovo Nordisk's launch of weight-loss and diabetes drugs Wegovy and Ozempic in India hinges on resolving supply issues. The company is scali...
- Novo Nordisk, maker of Ozempic and Wegovy sues two pharmacies for ‘selling impure drugs’Over alleged selling of contaminated drugs, two Florida-based pharmacies have been sued by Novo Nordisk. The company claims that the substa...
- Weight loss drugs can wreak havoc on your face, warn expertsA drug overdose is bad news for your beauty.
Load More
